Engineering longevity with the ZEUGMA hyperbaric chamber
As hyperbaric oxygen therapy moves beyond clinical medicine, HPO.TECH’s ZEUGMA hyperbaric chamber reflects growing interest in engineered recovery.…
High-dose curcumin fails to produce lasting gut microbiome changes in IBD patients
Even at pharmacological doses that flood the colon but barely enter the bloodstream, curcumin’s effects on the gut…
COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report
Four years after ICU admission, mortality remains strikingly high in ventilated COVID-19 ARDS patients, and many survivors continue…